Skip to main content

Rodolfo Staico, MD, PhD

Original Contribution
05/31/2017
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the...
05/31/2017
Journal of Invasive Cardiology
08/01/2008
Diabetes mellitus is associated with more aggressive coronary artery disease with almost 4 times the mortality rate and worse outcomes (including restenosis) after percutaneous coronary intervention.1–3 Stent implantation has become the...
Diabetes mellitus is associated with more aggressive coronary artery disease with almost 4 times the mortality rate and worse outcomes (including restenosis) after percutaneous coronary intervention.1–3 Stent implantation has become the...
Diabetes mellitus is associated...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Despite the recent advent of drug-eluting stents (DES), preparation of complex lesions (e.g., ostial, diffuse, fibrocalcified lesions and in-stent restenosis) before stent implantation remains an essential component of percutaneous coronary...
Despite the recent advent of drug-eluting stents (DES), preparation of complex lesions (e.g., ostial, diffuse, fibrocalcified lesions and in-stent restenosis) before stent implantation remains an essential component of percutaneous coronary...
Despite the recent advent of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved clinical outcomes of patients undergoing percutaneous coronary intervention (PCI), bare-metal stents are associated with a considerable risk of restenosis.1,2 The main cause of in-stent restenosis is excessive...
Although stenting has improved...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Feasibility and short- and mid-term safety of catheter-based intravascular brachytherapy (IVBT) has been demonstrated in several clinical trials.1–4 Moreover, randomized studies using IVBT (beta or gamma) have reported a significant reduction...
Feasibility and short- and mid-term safety of catheter-based intravascular brachytherapy (IVBT) has been demonstrated in several clinical trials.1–4 Moreover, randomized studies using IVBT (beta or gamma) have reported a significant reduction...
Feasibility and short- and...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
02/28/2017
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective,...
02/28/2017
Journal of Invasive Cardiology